23 Feb Opsis Therapeutics
David Gamm, M.D., Ph.D., Chief Science Officer and Co-Founder
Opsis Therapeutics was founded in 2016 as a joint venture with FUJIFILM. We are developing advanced treatments for patients suffering from inherited retinal disease and age-related macular degeneration. Our team developed methods to manufacture authentic human photoreceptors that offer potential for dramatic improvement in the standard of care for patients suffering from permanent vision loss. Recently, our success in developing, scale-up, and manufacture of human photoreceptors resulted in a partnership with BlueRock Therapeutics.